Recombinant human interleukin 11 (rhIL-11) is a pleiotropic cytokine t
hat stimulates bone marrow stem cells to proliferate and decreases int
estinal mucosal injury produced by cytoablative drugs and radiation in
animals. The effects of rhIL-11 were studied in a hamster model of or
al mucositis and in two rat models of inflammatory bowel disease (IBD)
. Oral mucositis was induced in male Golden Syrian hamsters with 5-flu
orouracil 60 mg/kg intraperitoneal, days 0 and 2. Peak mucositis occur
red by day 10 in vehicle treated animals. rhIL-11, given twice daily s
ubcutaneously, decreased the mucositis in a dose-dependent manner and
increased animal survival at all doses tested. In two models of IBD, t
he acetic acid-induced acute colonic injury model in Sprague-Dawley ra
ts and the transgenic Fischer 344 rats expressing human HLA-B27 and be
ta 2-microglobulin, rhIL-11 decreased the gross and microscopic damage
in the colons of these animals. These data suggest that rhIL-11 exert
s effects on the gastrointestinal mucosa which ameliorate responses to
injurious stimuli.